What's the next step in diagnosis for a patient with Cushing's disease suspected after a Low-Dose Dexamethasone Suppression Test (LDDST) showing more than 50% suppression of cortisol to a level of 6 ug/dL and an inconclusive MRI?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Next Diagnostic Step for Cushing's Disease with Inconclusive MRI and >50% Cortisol Suppression to 6 μg/dL on LDDST

For a patient with suspected Cushing's disease showing >50% suppression of cortisol to 6 μg/dL on LDDST and an inconclusive MRI, the next appropriate diagnostic step is bilateral inferior petrosal sinus sampling (BIPSS).

Understanding the Current Diagnostic Picture

  • The patient's LDDST shows >50% suppression of cortisol but only to 6 μg/dL, which is still above the normal cutoff of 1.8 μg/dL, suggesting Cushing's syndrome is still likely present 1
  • Normal cortisol suppression on LDDST would be to <1.8 μg/dL (50 nmol/L), and values above this threshold indicate abnormal feedback inhibition consistent with Cushing's syndrome 1
  • The >50% suppression pattern is suggestive of Cushing's disease (pituitary source) rather than ectopic ACTH or adrenal causes 1
  • With an inconclusive MRI and suggestive but not definitive LDDST results, further testing is needed to confirm the diagnosis and localize the source 1, 2

Diagnostic Algorithm for This Scenario

  1. Confirm ACTH dependency:

    • Measure plasma ACTH levels to confirm ACTH-dependent Cushing's syndrome 2, 3
    • ACTH levels >5 pg/mL indicate ACTH-dependent disease 3
    • ACTH levels >29 pg/mL have 70% sensitivity and 100% specificity for pituitary Cushing's disease 4
  2. Proceed to BIPSS:

    • With inconclusive MRI findings, BIPSS is indicated to differentiate between pituitary and ectopic sources 1, 2
    • BIPSS has diagnostic criteria of central-to-peripheral ACTH ratio ≥2:1 before CRH stimulation and ≥3:1 after stimulation 4
    • BIPSS has a sensitivity of 100% for diagnosing Cushing's disease 4

Why BIPSS is the Appropriate Next Step

  • According to the 2021 consensus guidelines, patients with lesions <6mm or inconclusive MRI findings should undergo BIPSS to confirm the diagnosis 1
  • The >50% suppression on LDDST suggests pituitary source, but this needs confirmation, especially with inconclusive imaging 1, 2
  • BIPSS is considered the gold standard test for differentiating between pituitary and ectopic sources of ACTH-dependent Cushing's syndrome 1, 4

Alternative Diagnostic Considerations

  • CRH stimulation test could be considered as an alternative, with a ≥20% increase in cortisol from baseline supporting pituitary origin (sensitivity 74-100%) 4
  • High-dose dexamethasone suppression test (8 mg) has lower sensitivity (71.85%) compared to BIPSS and is not recommended as the next step 5
  • The combined low-dose dexamethasone suppression-CRH test has been studied but does not add significant diagnostic value over BIPSS in this scenario 6, 7

Important Clinical Considerations

  • Ensure hypercortisolism is still active at the time of BIPSS to avoid false negative results 4
  • Measure dexamethasone levels along with cortisol during LDDST to improve test interpretability and rule out abnormal dexamethasone metabolism 1
  • Be aware that cyclic Cushing's syndrome can produce inconsistent results, requiring periodic re-evaluation 2

Following this diagnostic algorithm will provide the most definitive diagnosis for a patient with suspected Cushing's disease, inconclusive MRI, and partial suppression on LDDST.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cushing's Syndrome Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing ACTH-Dependent Cushing's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for ACTH-Dependent Cushing's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.